Intensity Therapeutics Revenue and Competitors

Westport, CT USA

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Intensity Therapeutics's estimated annual revenue is currently $2M per year.(i)
  • Intensity Therapeutics's estimated revenue per employee is $155,000

Employee Data

  • Intensity Therapeutics has 13 Employees.(i)
  • Intensity Therapeutics grew their employee count by -13% last year.

Intensity Therapeutics's People

NameTitleEmail/Phone
1
Founder, President & CEOReveal Email/Phone
2
Chief Financial OfficerReveal Email/Phone
3
VP Clinical OperationsReveal Email/Phone
4
VP, Regulatory Affairs and Quality AssuranceReveal Email/Phone
5
EVPReveal Email/Phone
6
EVP, Clinical DevelopmentReveal Email/Phone
7
VP Clinical OperationsReveal Email/Phone
8
DirectorReveal Email/Phone
9
Chief Financial OfficerReveal Email/Phone
10
Principal Accounting Officer and ControllerReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$0.2M1-80%N/AN/A
#2
$4.3M288%N/AN/A
#3
$9.8M66-11%N/AN/A
#4
$1.4M9350%N/AN/A
#5
$16.6M107-23%N/AN/A
#6
$4.5M29-22%N/AN/A
#7
$1.7M1157%N/AN/A
#8
$2.3M15-6%N/AN/A
#9
$0.3M4-43%N/AN/A
#10
$4M260%N/AN/A
Add Company

What Is Intensity Therapeutics?

Intensity Therapeutics is a clinical-stage biotechnology company pioneering a new immune-based approach to treat solid tumor cancers. We leverage our DfuseRxSM technology platform to create new drug formulations that, following direct injection, rapidly disperse throughout a tumor and diffuse therapeutic agents into cancer cells. Our lead product candidate, INT230-6, is currently being evaluated in a Phase 1/2 clinical study in patients with various types of advanced solid tumors. INT230-6 has the potential to induce an adaptive immune response that not only attacks the injected tumor, but also non-injected tumors and unseen micro-metastases. Intensity is based in Westport, Connecticut. For more information, please visit www.intensitytherapeutics.com and follow us on Twitter @IntensityInc.

keywords:N/A

N/A

Total Funding

13

Number of Employees

$2M

Revenue (est)

-13%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Intensity Therapeutics News

2022-03-22 - Intensity Therapeutics to Participate in the 34th Annual Roth ...

Intensity Therapeutics, Inc. is a privately held, phase 2 clinical-stage biotechnology company pioneering a new immune-based approach to treat...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$1M138%N/A
#2
$1.5M170%N/A
#3
$2.1M196%N/A
#4
$3M1946%N/A
#5
$1.7M19N/AN/A